Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mertelsmann

Showing results (81-90 of 366) with videos related to

Pageof 37
Sort By:
Arzneimittel-Forschung|March 1, 1988
[Cytokines in tumor therapy]A Lindemann, W Oster, F Herrmann, et al.
Leukemia & Lymphoma|June 5, 1998
The JAK-STAT pathway: signal transduction involved in proliferation, differentiation and transformationR M Weber-Nordt, R Mertelsmann, J Finke
Journal of Cancer Research and Clinical Oncology|January 1, 1997
Acute myelomonocytic leukemia secondary to synchronous carcinomas of the breast and lung, and to metachronous renal cell carcinomaC Pötzsch, S Fetscher, R Mertelsmann, et al.
MMW, Munchener Medizinische Wochenschrift|November 22, 1974
[Implantation of fetal thymus tissue in patients with progressive malignant neoplasms (author's transl)]R Mertelsmann, G Koch, V Schumpelick, et al.
International Journal of Cell Cloning|March 1, 1989
Minimal peripheral blood cells carrying clonal markers of B cell disorders: evidence for monoclonality of circulating lymphocytes in patients with multiple myelomaW Oster, A Lindemann, R Mertelsmann, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase I trial of recombinant human tumour necrosis factor alpha in patients with advanced malignancyH Gamm, A Lindemann, R Mertelsmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
BCL-2/JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseasesG Dölken, G Illerhaus, C Hirt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Interleukin-10 and phenomena of tolerance in interleukin-2 therapyM Engelhardt, U Brennscheidt, R Mertelsmann, et al.
Blut|October 1, 1989
Lymphokine activated killer cellsA Lindemann, F Herrmann, W Oster, et al.
Blood Cells|January 1, 1981
Phenotypic evaluation of chronic myeloid leukemiaM A Moore, R Mertelsmann, L M Pelus
Pageof 37

Showing results (81-90 of 366) with videos related to

Sort By:
Pageof 37
Arzneimittel-Forschung|March 1, 1988
[Cytokines in tumor therapy]A Lindemann, W Oster, F Herrmann, et al.
Leukemia & Lymphoma|June 5, 1998
The JAK-STAT pathway: signal transduction involved in proliferation, differentiation and transformationR M Weber-Nordt, R Mertelsmann, J Finke
Journal of Cancer Research and Clinical Oncology|January 1, 1997
Acute myelomonocytic leukemia secondary to synchronous carcinomas of the breast and lung, and to metachronous renal cell carcinomaC Pötzsch, S Fetscher, R Mertelsmann, et al.
MMW, Munchener Medizinische Wochenschrift|November 22, 1974
[Implantation of fetal thymus tissue in patients with progressive malignant neoplasms (author's transl)]R Mertelsmann, G Koch, V Schumpelick, et al.
International Journal of Cell Cloning|March 1, 1989
Minimal peripheral blood cells carrying clonal markers of B cell disorders: evidence for monoclonality of circulating lymphocytes in patients with multiple myelomaW Oster, A Lindemann, R Mertelsmann, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase I trial of recombinant human tumour necrosis factor alpha in patients with advanced malignancyH Gamm, A Lindemann, R Mertelsmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
BCL-2/JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseasesG Dölken, G Illerhaus, C Hirt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Interleukin-10 and phenomena of tolerance in interleukin-2 therapyM Engelhardt, U Brennscheidt, R Mertelsmann, et al.
Blut|October 1, 1989
Lymphokine activated killer cellsA Lindemann, F Herrmann, W Oster, et al.
Blood Cells|January 1, 1981
Phenotypic evaluation of chronic myeloid leukemiaM A Moore, R Mertelsmann, L M Pelus
Pageof 37